Disease, drug, and structure source integration¶
This workflow illustrates retrieval across public databases, not a new therapeutic or mechanistic conclusion by Topologica.
An MCP client can request:
map_disease_drug_landscapewith a source-checked MONDO identifier to retrieve Open Targets and ChEMBL disease-drug records.assess_target_druggabilitywith a source-checked UniProt accession to retrieve target evidence and an explicitly heuristic local summary.analyze_structural_confidencewith the same source-checked accession to inspect AlphaFold DB predicted coordinates and confidence information.
Gene products, drug indications, structural models, and disease records are different evidence objects. A drug's reported indication does not show that the isolated AlphaFold structure represents a fusion protein, mutation, binding state, or treatment response.
Use source identifiers and provenance for any downstream scientific work. The earlier June 2026 numerical transcript is historical, not a maintained assertion about current source data or clinical actionability.